Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Serum levels of pigment epithelium-derived factor (PEDF) are independently associated with procollagen III N-terminal peptide levels in patients with nonalcoholic fatty liver disease.

Hyogo H, Yamagishi S, Maeda S, Kimura Y, Ishitobi T, Chayama K.

Clin Biochem. 2012 Dec;45(18):1554-7. doi: 10.1016/j.clinbiochem.2012.07.106. Epub 2012 Aug 3.

PMID:
22884488
2.

Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis.

Yilmaz Y, Eren F, Ayyildiz T, Colak Y, Kurt R, Senates E, Tuncer I, Dolar E, Imeryuz N.

Clin Chim Acta. 2011 Nov 20;412(23-24):2296-9. doi: 10.1016/j.cca.2011.08.025. Epub 2011 Aug 24.

PMID:
21888902
3.

Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes.

Nakamura K, Yamagishi S, Adachi H, Kurita-Nakamura Y, Matsui T, Inoue H.

Diabetes Metab Res Rev. 2009 Jan;25(1):52-6. doi: 10.1002/dmrr.820.

PMID:
18677713
4.

Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes.

Jenkins AJ, Zhang SX, Rowley KG, Karschimkus CS, Nelson CL, Chung JS, O'Neal DN, Januszewski AS, Croft KD, Mori TA, Dragicevic G, Harper CA, Best JD, Lyons TJ, Ma JX.

Diabet Med. 2007 Dec;24(12):1345-51. Epub 2007 Oct 29.

PMID:
17971181
5.

Serum levels of pigment epithelium-derived factor, a novel marker of insulin resistance, are independently associated with fasting apolipoprotein B48 levels in humans.

Tahara N, Yamagishi S, Tahara A, Takeuchi M, Imaizumi T.

Clin Biochem. 2012 Nov;45(16-17):1404-8. doi: 10.1016/j.clinbiochem.2012.07.095. Epub 2012 Jul 22.

PMID:
22827961
6.

Serum levels of pigment epithelium-derived factor (PEDF) are inversely associated with circulating levels of dipeptidyl peptidase-4 (DPP-4) in humans.

Tahara N, Yamagishi S, Matsui T, Nishino Y, Honda A, Tahara A, Igata S, Fukumoto Y.

Int J Cardiol. 2015 Apr 1;184:14-6. doi: 10.1016/j.ijcard.2015.02.010. Epub 2015 Feb 10.

PMID:
25705004
7.

Serum pigment epithelium-derived factor levels are independently correlated with the presence of coronary artery disease.

Wang F, Ma X, Zhou M, Pan X, Ni J, Gao M, Lu Z, Hang J, Bao Y, Jia W.

Cardiovasc Diabetol. 2013 Apr 1;12:56. doi: 10.1186/1475-2840-12-56.

8.

Serum level of pigment epithelium derived factor (PEDF) is an independent determinant of resting heart rate in Japanese subjects.

Nakamura K, Yamagishi S, Adachi H, Matsui T, Kurita Y, Inoue H.

Int J Cardiol. 2009 Aug 14;136(2):245-7. doi: 10.1016/j.ijcard.2008.04.055. Epub 2008 Jul 14.

PMID:
18625531
9.
10.

Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome.

Yamagishi S, Adachi H, Abe A, Yashiro T, Enomoto M, Furuki K, Hino A, Jinnouchi Y, Takenaka K, Matsui T, Nakamura K, Imaizumi T.

J Clin Endocrinol Metab. 2006 Jun;91(6):2447-50. Epub 2006 Mar 7.

PMID:
16522692
11.

Pigment epithelium-derived factor increases in type 2 diabetes after treatment with metformin.

Akın S, Aksoy DY, Cınar N, Aydın K, Karaağaoğlu E, Arıyürek M, Gülçelik NE, Usman A, Gürlek A.

Clin Endocrinol (Oxf). 2012 Dec;77(6):852-6. doi: 10.1111/j.1365-2265.2012.04341.x.

PMID:
22248012
12.

Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans.

Tahara N, Yamagishi S, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Mohar D, Ishibashi M, Hayabuchi N, Imaizumi T.

Atherosclerosis. 2011 Nov;219(1):311-5. doi: 10.1016/j.atherosclerosis.2011.06.022. Epub 2011 Jun 17.

PMID:
21733518
13.

Serum levels of pigment epithelium-derived factor (PEDF) are an independent determinant of insulin resistance in patients with essential hypertension.

Nakamura K, Yamagishi S, Adachi H, Matsui T, Kurita Y, Imaizumi T.

Int J Cardiol. 2010 Aug 6;143(1):96-8. doi: 10.1016/j.ijcard.2008.11.169. Epub 2008 Dec 13.

PMID:
19073347
14.

Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with acanthosis nigricans in obese adolescents.

Galhardo J, Hunt LP, Shield JP.

Diabet Med. 2012 Jul;29(7):e117-20. doi: 10.1111/j.1464-5491.2012.03592.x.

PMID:
22288782
15.

Positive association of circulating levels of advanced glycation end products (AGEs) with pigment epithelium-derived factor (PEDF) in a general population.

Yamagishi S, Matsui T, Adachi H, Takeuchi M.

Pharmacol Res. 2010 Feb;61(2):103-7. doi: 10.1016/j.phrs.2009.07.003. Epub 2009 Jul 25.

PMID:
19635565
16.

[Change and significance of serum pigment epithelium-derived factor in type 2 diabetic nephropathy].

Chen HB, Jia WP, Lu JX, Bao YQ, Li Q, Lu FD, Lu W, Yu HY, Xiang KS.

Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1230-3. Chinese.

PMID:
17686253
17.

Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss.

Sabater M, Moreno-Navarrete JM, Ortega FJ, Pardo G, Salvador J, Ricart W, Frühbeck G, Fernández-Real JM.

J Clin Endocrinol Metab. 2010 Oct;95(10):4720-8. doi: 10.1210/jc.2010-0630. Epub 2010 Jul 14.

PMID:
20631025
18.

Effect of weight loss on serum pigment epithelium-derived factor levels.

Tschoner A, Sturm W, Ress C, Engl J, Kaser S, Laimer M, Laimer E, Klaus A, Tilg H, Patsch JR, Ebenbichler CF.

Eur J Clin Invest. 2011 Sep;41(9):937-42. doi: 10.1111/j.1365-2362.2011.02482.x. Epub 2011 Feb 14.

PMID:
21314826
19.

Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.

Yoneda M, Iwasaki T, Fujita K, Kirikoshi H, Inamori M, Nozaki Y, Maeyama S, Wada K, Saito S, Terauchi Y, Nakajima A.

Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S15-21.

PMID:
17331160
20.

PEDF and septic shock.

Nakamura T, Yamagishi SI.

Curr Mol Med. 2010 Apr;10(3):312-6. Review.

PMID:
20236051

Supplemental Content

Support Center